Role of Bumetanide in Treatment of Autism
Role of Bumetanide in Treatment of Autism is one of 9,000 trials in the TrialMatch dataset. Key details — Condition(s): Autism; Status: Recruiting; Phase: Phase 3.
| Condition(s) | Autism |
|---|---|
| Status | Recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Summary | Role of bumetanide in Autism |
| Who can participate | Inclusion Criteria: 1. All patients with ASD diagnosed by CARS rating Scale⩾30. 2. Age of patients range between (3-12) years. Exclusion Criteria: * Patients with ASD associated with neurological antecedents (including epilepsies and febrile seizures), hepatic, renal dysfunction or electrocardiogram abnormalities and syndromatic children(Rett). |
| Ages | 3 Years to 12 Years |
| Sex | All |
| Lead sponsor | Sherief Abd-Elsalam |
| Locations | Tanta, Egypt |
| Start date | 2021-01-01 |
| NCT ID | NCT04766177 |
| Official listing | https://clinicaltrials.gov/study/NCT04766177 |